These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6989198)

  • 21. Decreased prostacyclin levels in sickle cell disease.
    Longenecker GL; Mankad V
    Pediatrics; 1983 May; 71(5):860-1. PubMed ID: 6340054
    [No Abstract]   [Full Text] [Related]  

  • 22. [State of prostanoid-regulating function of the lungs in patients subjected to thoracic surgery].
    Timerbaev VKh; Kontarev SN
    Anesteziol Reanimatol; 1997; (2):52-4. PubMed ID: 9221690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass.
    Zapol WM; Peterson MB; Wonders TR; Kong D; Watkins WD
    Trans Am Soc Artif Intern Organs; 1980; 26():556-60. PubMed ID: 7018060
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of various prostanoids on gallbladder muscle.
    Wood JR; Saverymuttu SH; Ashbrooke AB; Stamford IF
    Adv Prostaglandin Thromboxane Res; 1980; 8():1569-71. PubMed ID: 6990729
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostacyclin in pregnancy.
    Lewis PJ; Boylan P; Friedman LA; Hensby CN; Downing I
    Br Med J; 1980 Jun; 280(6231):1581-2. PubMed ID: 7000245
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats.
    Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K
    Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overactivity and structural changes in the chronically ischemic bladder.
    Azadzoi KM; Tarcan T; Kozlowski R; Krane RJ; Siroky MB
    J Urol; 1999 Nov; 162(5):1768-78. PubMed ID: 10524933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder.
    Azadzoi KM; Shinde VM; Tarcan T; Kozlowski R; Siroky MB
    J Urol; 2003 May; 169(5):1885-91. PubMed ID: 12686867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous mechanisms that regulate prostacyclin release.
    Gryglewski RJ; Spławiński J; Korbut R
    Adv Prostaglandin Thromboxane Res; 1980; 7():777-87. PubMed ID: 6989204
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostacyclin in haemodialysis and charcoal haemoperfusion.
    Weston MJ
    Contrib Nephrol; 1983; 36():68-72. PubMed ID: 6340952
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting.
    Kieler-Jensen N; Milocco I; Kirnö K; Houltz E; Ricksten SE
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):741-7. PubMed ID: 8910153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of prostacyclin in plasma.
    Jørgensen KA; Stoffersen E; Dyerberg J
    Lancet; 1979 Jun; 1(8130):1352. PubMed ID: 87815
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacology of prostacyclin and prostacyclin-like compounds].
    Lakin KM; Baluda VP; Makarov VA
    Vestn Akad Med Nauk SSSR; 1982; (5):81-91. PubMed ID: 7048789
    [No Abstract]   [Full Text] [Related]  

  • 34. [Continuously superfused blood-bathed organ bioassay].
    Zheng YF
    Sheng Li Ke Xue Jin Zhan; 1982 Oct; 13(4):376-9. PubMed ID: 7167802
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative roles of cyclooxygenase and nitric oxide synthase pathways in ischemia-induced increased contraction of cavernosal smooth muscle.
    Azadzoi KM; Krane RJ; Saenz de Tejada I; Goldstein I; Siroky MB
    J Urol; 1999 Apr; 161(4):1324-8. PubMed ID: 10081902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostacyclin in the cardiovascular system.
    Moncada S; Vane JR
    Adv Prostaglandin Thromboxane Res; 1980; 6():43-60. PubMed ID: 6992536
    [No Abstract]   [Full Text] [Related]  

  • 37. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial deficiency of a plasma factor stimulating vascular prostacyclin activity.
    Remuzzi G; Marchesi D; Misiani R; Mecca G; de Gaetano G; Donati MB
    Thromb Res; 1979; 16(3-4):517-25. PubMed ID: 390760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.